18. Imaging findings
• Multiloculated cystic lesion involving left amygdala, left
hippocampal gyrus, with extension to left choroidal fissure, left
perimesencephalic cistern and temporal horn of lateral ventricle
• Multiple cystic lesion mainly in gray matter of left hippocampus,
left parahippocampal gyrus, left fusiform gyri, left inferior frontal
lobe, inferior part of left insular cortex, left caudate nucleus, left
globus pallidus, left putamen, left thalamus, hypothalamus, left
parietal cortex
• Showing slightly hyperSI to CSF on T1WI, isoSI to CSF on T2WI
and partially suppressed with high SI rim on FLAIR
• No restricted diffusion, paramagnetic substance/blood product
• No definite enhancement
20. DNET
• Benign mixed glial-neuronal neoplasm (WHO grade I)
• Frequently associated with cortical dysplasia
• Young patients with longstanding partial complex seizure
• Frequently drug resistant
• Common age: children and young adult (2nd – 3rd decades)
• Rare malignant transformation
• No to very slow increased in size
21. DNET
• Sharply demarcated cystic/multicystic mass arising from
cortical or deep grey matter
• Cystic “bubbly” intracortical mass
• Minimal or no mass effect
• No surrounding edema
• Usually not enhanced
• Location: any region of supratentorial cortex
• Most common: temporal lobe (45-68%)
• Frontal lobe (~30%)
22. CT findings
• Cortical/subcortical
• Low density
• Calcification ~ 20-36%
• Usually non-enhancing
• Faint nodular or patchy
enhancement in 20%
• Higher incidence of recurrence
23. MRI findings
• T1WI
• Multilobular hypointense bubbly mass
• Cortex, may extend to subcortical white matter and (rarely) basal
ganglia
• T2WI
• Multilobular very hyperintense on T2
• FLAIR
• Mixed hypo-isointense SI
• No peritumoral edema
• DWI
• High diffusibility
• T1WI +C
• Usually not enhanced
• Focal punctate or ring enhancement in up to 30%
25. PET
• F-18 FDG PET: Glucose hypometabolism
• Lower 11C-methionine uptake than in ganglioglioma or
glioma
26. Cortical based tumors
• Usually present with complex seizures
DDx
• Oligodendroglioma
• Ganglioglioma
• Pleomorphic xanthoastrocytoma (PXA)
• DNET
27. Oligodendroglioma
• WHO grade II
• Well-differentiated, slowly
growing but diffusely infiltrating
cortical/subcortical tumor
• Young to middle aged patient
• Variant e.g. Oligoastrocytoma,
anaplastic oligodendroglioma
>> more aggressive
• Best diagnostic clue:
• partially calcification
subcortical/cortical mass in
middle aged adult
• Typically T2 heterogeneous,
hyperintense mass
• Typical heterogeneous
enhancement
NECT
T1 +C
FLAIR
T1
29. Ganglioglioma
• Most common tumor causing
temporal lobe epilepsy (TLE)
• Well differentiated, slowly
growing neuroepithelial tumor
composed of neoplastic ganglion
cells and neoplastic glial cells
• Best diagnostic clue
• Partially cystic with mural
nodule, enhancing, cortical
based mass in child/young
adult with TLE
• In younger pt (< 10 years), more
cystic and larger
T2
T1 +C
30. Pleomorphic xanthoastrocytoma
• Low-grade WHO grade II
astrocytoma variant
• Rare tumor of childhood and
adolescents with chronic epilepsy
• Most common site: temporal lobe
• Peripheral located hemispheric
mass
• The overlying dura may be
thickened and enhancing (unlike
ganglioglioma)
• Best diagnostic clue:
• Supratentorial cortical mass
with adjacent enhancing dural
tail
• Cyst and enhancing mural
nodule
T1 +C
T2 T1 +C